Medlive Technology Co., Ltd.'s (HKG:2192) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Medlive Technology (HKG:2192) has had a great run on the share market with its stock up by a significant 27% over the last three months. As most would know, fundamentals are what usually guide marke
Medical Connect (02192.HK) plans to acquire 60% of the shares in Lingbo Market Information Consulting (Shanghai) for RMB 33.93 million
GLONGHUI, Oct. 12 (02192.HK) announced that on October 12, 2023, Jinye Tiancheng Beijing, the seller (Wu Ning, Chen Lifei, Gao Yifan) and the target company Ling Bo Market Information Consulting (Shanghai) Co., Ltd. signed a share transfer agreement. According to this, Seller A, Seller B, and Seller C respectively agreed to sell 42%, 9%, and 9% of the shares of the target company, while Jinye Tiancheng Beijing agreed to buy 60% of the shares of the target company at a cost of RMB 33.93 million.. The target company is mainly engaged in the business of providing research services to pharmaceutical companies. It has
Additional Considerations Required While Assessing Medlive Technology's (HKG:2192) Strong Earnings
Medlive Technology Co., Ltd.'s (HKG:2192) robust earnings report didn't manage to move the market for its stock. Our analysis suggests that shareholders have noticed something concerning in the numbe
Medlive Technology Insider Lowered Holding By 58% During Last Year
Viewing insider transactions for Medlive Technology Co., Ltd.'s (HKG:2192 ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders i
Medical Connect (02192.HK) received FIL Limited's holdings increased by 485,500 shares
GLONGHUI, September 26 | According to the latest equity disclosure information from the Stock Exchange, on September 20, 2023, Medical Connect (02192.HK) received FIL Limited's holdings on the market to increase its holdings by 485,500 shares at an average price of HK$7.4669 per share, involving approximately HK$3,6252 million. After the increase in holdings, the latest number of shares held by FIL Limited was 656.674 million shares, and the shareholding ratio increased from 8.97% to 9.03%.
MEDLIVE: INTERIM REPORT 2023
MEDLIVE: SUPPLEMENTAL ANNOUNCEMENT TO 2022 ANNUAL REPORT
[Brokerage Focus] Western Securities maintains a “buy” rating of Yimaitong (02192), indicating that its precision marketing business has grown significantly
According to the Western Securities Research Report, 23H1 Medical Connect (02192) achieved revenue of 174 million yuan (+31.5%); net profit of 98.72 million yuan (+266.0%); and adjusted net profit of 120 million yuan (+122.0%). Other income for the period was approximately $82.85 million ($26.03 million for the same period of 21H1), mainly due to increased interest income and government subsidies. The gross profit margin was 60.6% (-8.5 pcts). The decline in gross margin was mainly due to mergers and acquisitions of Ishicheng Medical and the relatively low gross margin RWE business expansion during the period. The sales/management/finance expense ratios for the period were 9, respectively
Medlive Technology's Profit Soars 266% in H1
Medlive Technology (HKG:2192) recorded a 266% rise in attributable profit for the six months ended June 30 to 98.7 million yuan from 27 million yuan during the year-ago period. Diluted earnings per sh
MEDLIVE To Go Ex-Dividend On November 7th, 2023 With 0.1165 HKD Dividend Per Share
August 30th - $MEDLIVE(02192.HK)$ is trading ex-dividend on November 7th, 2023. Shareholders of record on November 8th, 2023 will receive 0.1165 HKD dividend per share on December 4th, 2023. The e
Yimaitong (02192) released interim results. Adjusted net profit of 120 million yuan increased 122% year-on-year, and interim interest rate of 10.67 points per share
Yimaitong (02192) announced its interim results for the 6 months ended June 30, 2023. The group's beneficiaries...
MEDLIVE: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Medical Connect (02192.HK) received FIL Limited's holdings increased by 532,500 shares
Glonghui, August 18 | According to the latest equity disclosure information from the Stock Exchange, on August 14, 2023, Imaitong (02192.HK) received FIL Limited's holdings of 532,500 shares at an average price of HK$59,486 per share on the market, involving approximately HK$3.1676 million. After the increase in holdings, the latest number of shares held by FIL Limited was 65.5454 million shares, and the shareholding ratio increased from 8.94% to 9.02%.
Medical Connect (02192.HK) will hold a board meeting on August 29 to approve the interim results
Glonway, August 16, 丨Medical Connect (02192.HK) announced that the company will hold a board meeting on August 29, 2023 to consider and approve the interim results of the company and its subsidiaries for the six months ended June 30, 2023, and consider the payment of interim dividends (if any).
MEDLIVE: DATE OF BOARD MEETING
Earnings Growth of 149% Over 1 Year Hasn't Been Enough to Translate Into Positive Returns for Medlive Technology (HKG:2192) Shareholders
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. Investors in Medlive Technolo
Changes in Hong Kong stocks | Medical Connect (02192) once rose more than 7% in early trading and is expected to increase the profit from the mother's return to no less than 90 million yuan year-on-year in the first half of the year
The Zhitong Finance App learned that Medical Connect (02192) once rose more than 7% in early trading. As of press release, it rose 4.13% to HK$6.55, with a turnover of HK$10.3963 million. According to the news, YimaTong announced yesterday that the board of directors expects a significant increase in profits due to owners of the parent company in the first half of 2023, up to no less than RMB 90 million over the previous year. The increase in revenue mainly benefited from the return to normal hospital diagnosis and treatment after the pandemic, the acceleration of the approval process for new drugs, and the accelerated recovery of product sales and marketing work for pharmaceutical and medical device company customers.
Medlive Technology to More Than Triple H1 Profit
Medlive Technology (HKG:2192) expects a rise in attributable profit to at least 90 million yuan for the six months ended June 30, up from 26.97 million during the year-ago period. The professional phy
Medical Connect (02192) Fa Yingxi expects the profit due to parent company owners to rise sharply to no less than 90 million yuan in the first half of the year
According to the Zhitong Finance App, Medical Connect (02192) announced that the board of directors expects a significant increase in profits due to parent company owners in the first half of 2023, up to no less than RMB 90 million from the same period in 2022.
MEDLIVE: POSITIVE PROFIT ALERT